InCrowd—the life science, real-time market insights pioneer—annually asks physicians from its proprietary crowd of healthcare professionals (HCPs) to share their perspectives on US healthcare for the coming year. On February 11, 2020 at 1:00 pm ET, please join as Diane Hayes, PhD, InCrowd Co-founder and Board Member and Daniel S. Fitzgerald, InCrowd CEO and President, review the findings.

Key learnings:

  • Considerations regarding the potential impact of the 2020 presidential election
  • Trends and changes in physicians’ views compared to years past
  • Physicians’ perspectives on drug prices in 2020
  • Perceived healthcare priorities
  • Thoughts on ways to reduce healthcare costs
  • The fate of various aspects of healthcare reform
  • Perspectives on the opioid epidemic
  • Views on the implications of health innovations and privacy

Featured Speakers

Diane Hayes, PhD

Co-Founder & Board Member
InCrowd

Dr. Diane Hayes gravitated to epidemiology while in graduate school, drawn by a love of data. She spent time in academia working on large, NIH-sponsored clinical trials, but the bulk of her career has been in the business world. As a co-founder and board member of InCrowd, Dr. Hayes helps to steer the long-term, strategic direction of the company.

Daniel S. Fitzgerald

CEO & President
InCrowd

Daniel S. Fitzgerald is chief executive officer and president of InCrowd, a SARORAS company. With 25 years of successful commercial and general management experience, Mr. Fitzgerald’s focus is in data-driven insights and analytical, tech-enabled businesses, having served many diverse vertical markets and customers.

Date:  Tuesday, February 11, 2020
Time:  1pm ET / 10am PT
Duration:  1 Hour

Register now for this webinar